article thumbnail

Khosla Ventures’ Alex Morgan on biotech’s challenges and solving drug delivery

Bio Pharma Dive

The life sciences investor has backed a number of startups working on technologies for delivering and manufacturing cell and gene medicines.

article thumbnail

Alkermes, continuing transformation, plans to split in two

Bio Pharma Dive

The biotech’s transition from drug delivery specialist to maker of novel medicines led to competing neuroscience and oncology divisions. The latter will soon become a separate company.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

This intersection will be remembered as one of the most significant achievements in science and medicine”. The next wave came from early research into liposomes and lipid nanoparticles, both of which are used for drug delivery. Lipid nanoparticle drug delivery was in the spotlight during the Covid-19 pandemic.

article thumbnail

Nonclinical Pulmonary Drug Delivery: Setting Up Your Inhalation Drug Study for Success

Camargo

Medicine has been delivered by inhalation for decades to treat human respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and airway infection. Why is pulmonary drug delivery a complex challenge? How can we accomplish drug delivery to the lungs in nonclinical studies?

article thumbnail

Orexo, leveraging drug delivery tech, seeks FDA approval of nasal high-dose opioid rescue medicine

Fierce Pharma

Orexo, leveraging drug delivery tech, seeks FDA approval of nasal high-dose opioid rescue medicine ntaylor Tue, 02/07/2023 - 08:18

article thumbnail

New smart drug delivery system may help treatment for neurological disorders

Scienmag

Drug delivery technology is aimed at helping people with spinal cord and other nervous system disorders Credit: KiBum Lee, Letao Yang and Brian M. The system, […].

article thumbnail

Innovate UK funding for new precision cancer treatment technology

pharmaphorum

Sixfold Bioscience and Medicines Discovery Catapult awarded Innovate UK grant to pursue ground-breaking project. Programmable Oligonucleotide Delivery System (PODS), developed by Sixfold Bioscience, is a versatile system which delivers short interfering RNA (siRNA) gene silencing cargo to specific cancer cells.